<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04848376</url>
  </required_header>
  <id_info>
    <org_study_id>REC108-16</org_study_id>
    <nct_id>NCT04848376</nct_id>
  </id_info>
  <brief_title>Post-Market Clinical Follow-up Study of A-SPINE's Products</brief_title>
  <official_title>Post-Market Clinical Follow-up Study of A-SPINE's Products</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>A-Spine Asia Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>A-Spine Asia Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a post-market clinical follow-up study that use questionnaires such as Visual Analog&#xD;
      Scale (VAS), the Neck Disability Index (NDI), or the Oswestry Disability Index (ODI) to&#xD;
      compare the clinical improvement effects before and after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of study is to confirm the safety and and performance of the A-SPINE's products&#xD;
      for using 2 years. This post-market clinical follow-up study use questionnaires such as&#xD;
      Visual Analog Scale (VAS), the Neck Disability Index (NDI), or the Oswestry Disability Index&#xD;
      (ODI) to evaluate the clinical improvement effects. Subjects will be evaluated at&#xD;
      pre-operation, 6 months, 12 months, and 2 years post treatment. Finally, analyze the clinical&#xD;
      outcome, fusion rate, and adverse events.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2019</start_date>
  <completion_date type="Anticipated">September 8, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 8, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale- Change from baseline at 2 year</measure>
    <time_frame>Change from baseline at 2 year</time_frame>
    <description>Visual Analogue Scale is a patient-reported outcome measure. The scale ranges from 0 to 10. A score of 0 represents no pain, while a score of 10 represents extreme pain. Compare baseline and postoperative improvement VAS scores.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neck Disability Index</measure>
    <time_frame>Baseline, 6 months, 12 months, 24 months</time_frame>
    <description>The NDI is a questionnaire that is commonly used in clinical trials to measure the self-reported functional status of patients with neck pain.The ten questions are measured on a 6-point scale from 0 (no disability) to 5 (full disability). Compare baseline and postoperative improvement NDI scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>Baseline, 6 months,12 months, 24 months</time_frame>
    <description>The ODI is a questionnaire that is commonly used in clinical trials to measure the self-reported functional status of patients with neck pain.The ten questions are measured on a 6-point scale from 0 (no disability) to 5 (full disability). Compare baseline and postoperative improvement ODI scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Device-related Adverse Events</measure>
    <time_frame>Baseline, 6 months,12 months, 24 months</time_frame>
    <description>Adverse events associated with the device will be assessed at each follow-up visit and the number of cases at the 2-year follow-up will be counted.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fusion Rate</measure>
    <time_frame>Baseline, 6 months,12 months, 24 months</time_frame>
    <description>Use X-ray or CT to detect the spine fusion.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <condition>Kyphosis</condition>
  <condition>Scoliosis</condition>
  <condition>Trauma</condition>
  <condition>Tumor</condition>
  <condition>Stenosis</condition>
  <condition>Pseudoarthrosis of Spine</condition>
  <condition>Deformity</condition>
  <arm_group>
    <arm_group_label>Spine surgery</arm_group_label>
    <description>Use these system:&#xD;
(1) SmartLoc (2) SmartLoc Evo(3) Winloc (4) Vigor PEEK Cervical Disc Spacer (5) Combo C (6) Polymer Lumbar Disc Spacer (7) X'Plo (8) Rainboo (9) Combo L</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>(1) SmartLoc (2) SmartLoc Evo (3) Winloc(4) Vigor PEEK Cervical Disc Spacer (5) Combo C (6) Polymer Lumbar Disc Spacer (7) X'Plo (8) Rainboo (9) Combo L</intervention_name>
    <description>As long as there are patients using the above device, conduct questionnaire interview.</description>
    <arm_group_label>Spine surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients have implanted an A-SPINE device to stabilize the spine and/or restore the&#xD;
        height of disc.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is above 20 years of age;&#xD;
&#xD;
          -  Subject is indicated for A-SPINE Spinal Fixation System;&#xD;
&#xD;
          -  Subject is willing and able to provide informed consent to participate in the study;&#xD;
&#xD;
          -  Subject is willing and able to understand the purpose of the study, his/her role, and&#xD;
             is available to return to the clinic/hospital for all required follow-up visits.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects will be excluded if, in the opinion of the Investigator, the subject does not&#xD;
             qualify based on approved labeling requirements or Subject Inclusion Criteria.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bryan Huang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taichung Tzu Chi Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shu-Ting LIU, MS</last_name>
    <phone>+886-2-29267088</phone>
    <phone_ext>621</phone_ext>
    <email>charlotte@aspine.com.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taichung Tzu Chi Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>427213</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryan Huang, MD</last_name>
      <phone>+886-4-36060666</phone>
      <phone_ext>3129</phone_ext>
    </contact>
    <investigator>
      <last_name>Bryan Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2021</study_first_posted>
  <last_update_submitted>April 14, 2021</last_update_submitted>
  <last_update_submitted_qc>April 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scoliosis</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
    <mesh_term>Kyphosis</mesh_term>
    <mesh_term>Pseudarthrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

